SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?


To: KeepItSimple who wrote (57457)5/19/1999 9:27:00 PM
From: Bill Harmond  Read Replies (2) | Respond to of 164684
 
>>Everyone knows there is less than 1 month left in this market before the whole thing utterly implodes- and everyone is getting while the getting is still good.

My associates are out of the loop I guess.



To: KeepItSimple who wrote (57457)5/19/1999 11:18:00 PM
From: MSI  Read Replies (1) | Respond to of 164684
 
He has been approached by two investment bankers this week. One wants to take him public in 60 days.

I'm having a somewhat similar experience. Make hay while the sun is shining.

Wouldn't you?

They actually have a duty to their shareholders to wring as much liquidity out of the environment as possible. Imagine this: $2b of 4.5% money at 9% can float a zero-profit company forever.

I know you'd do that



To: KeepItSimple who wrote (57457)5/20/1999 7:56:00 AM
From: Glenn D. Rudolph  Respond to of 164684
 
Internet-Based Pharmacy Drugstore.com Files For $67.5 Million IPO
Dow Jones On Line - May 19, 1999 19:31

WASHINGTON -(Dow Jones)- Drugstore.com Inc., an online pharmacy backed by Amazon.com, filed for an initial public offering Wednesday of $67.5 million in common shares.

Amazon.com (AMZN) owns 40% of the Bellevue, Wash.-based company, which sells prescription drugs and brand-name health and beauty aids through its electronic-commerce Web site. Amazon.com will buy $10 million of the company's shares at the initial public offering price in a concurrent offering that isn't being underwritten, Drugstore.com said in a filing with the Securities and Exchange Commission.

Morgan Stanley Dean Witter, Donaldson, Lufkin & Jenrette and Thomas Weisel Partners LLC will underwrite the offering.

Drugstore.com and its competitors are scrambling to grab a piece of the lucrative U.S. pharmacy market with its $150 billion in annual sales. Licensed to dispense drugs in 44 states, Drugstore.com is the first online pharmacy to announce plans to go public. Its competitors include PlanetRx and Soma.com, as well as online pharmacies operated by traditional drugstore chains which are wary of Internet upstarts encroaching on their turf.

CVS Corp. (CVS), the largest drugstore chain in the U.S. based on the number of stores, on Monday announced plans to buy Soma.com for $30 million. The retailer already operates its own Web site but wanted to step up its online presence to better position itself to capitalize on the burgeoning Internet health-care market.

Aside from Amazon.com, Drugstore.com is linked with high-profile Healtheon Corp. (HLTH), an online health-information provider which earlier Wednesday confirmed that it is considering a $5.5 billion stock-swap merger with WebMD Inc. Last month, Healtheon announced it would add Drugstore.com as a preferred pharmacy in its consumer-health portal site.

Copyright (c) 1999 Dow Jones & Company, Inc.

All Rights Reserved.